James R. Cerhan

Research interests

Publications

• Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes

  Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0016-8

• Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1709974

• Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study

  Blood · 2017 · https://doi.org/10.1182/blood-2017-03-769620

• 2016 US lymphoid malignancy statistics by World Health Organization subtypes

  CA A Cancer Journal for Clinicians · 2016 · https://doi.org/10.3322/caac.21357

• Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents

  The Lancet · 2016 · https://doi.org/10.1016/s0140-6736(16)30175-1

• Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

  Journal of Clinical Oncology · 2015 · https://doi.org/10.1200/jco.2014.59.7534

• Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.51.5866

• Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project

  JNCI Monographs · 2014 · https://doi.org/10.1093/jncimonographs/lgu013

• A Pooled Analysis of Waist Circumference and Mortality in 650,000 Adults

  Mayo Clinic Proceedings · 2014 · https://doi.org/10.1016/j.mayocp.2013.11.011

• ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

  Blood · 2014 · https://doi.org/10.1182/blood-2014-04-571091

• Type I and II Endometrial Cancers: Have They Different Risk Factors?

  Journal of Clinical Oncology · 2013 · https://doi.org/10.1200/jco.2012.48.2596

• Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

  Proceedings of the National Academy of Sciences · 2012 · https://doi.org/10.1073/pnas.1121343109

• Body-Mass Index and Mortality among 1.46 Million White Adults

  New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa1000367

• Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium

  Blood · 2008 · https://doi.org/10.1182/blood-2007-10-119974

• Hepatitis C and Non-Hodgkin Lymphoma Among 4784 Cases and 6269 Controls From the International Lymphoma Epidemiology Consortium

  Clinical Gastroenterology and Hepatology · 2008 · https://doi.org/10.1016/j.cgh.2008.02.011

• Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

  Nature Genetics · 2008 · https://doi.org/10.1038/ng.89

• Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium

  The Lancet Oncology · 2005 · https://doi.org/10.1016/s1470-2045(05)70434-4

• Epidemiologic Evaluation of Measurement Data in the Presence of Detection Limits

  Environmental Health Perspectives · 2004 · https://doi.org/10.1289/ehp.7199

• Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study

  Arthritis & Rheumatism · 2004 · https://doi.org/10.1002/art.11434

• Municipal Drinking Water Nitrate Level and Cancer Risk in Older Women: The Iowa Women’s Health Study

  Epidemiology · 2001 · https://doi.org/10.1097/00001648-200105000-00013

Current projects

No projects listed.